As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

A study has suggested that the use of weight-loss jabs may be associated with wider health benefits, including a lower risk ...

A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

Official data shows that since 2019, this medication has been linked to 23 deaths and 1,179 serious adverse reactions in the ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...

While it's illegal to sell certain substances without a prescription, it's possible that you could be sold fake weight loss ...

Recent research reveals that weight-loss injections reduce the risk of 42 health conditions in people with diabetes, ...